Abogen Biosciences is a clinical-stage biotechnology company focused on developing transformative medicines through RNA innovations. Founded in 2019 and based in Suzhou, it has built full-scale in-house capabilities covering the entire mRNA drug development cycle—from protein engineering, mRNA sequence design and synthesis, to lipid nanoparticle (LNP) delivery, formulation, and commercial-scale manufacturing.
No recent news for this company.
No recent deals for this company.